The Latest in Thrombosis

Hematology Times

Therapy can extend half-life of FVIII

May 23, 2018

Hematology Times

Emicizumab reduces bleeding in hemophilia A

May 22, 2018

Hematology Times

FDA approves drug for thrombocytopenia in CLD

May 22, 2018

Thrombosis

Hematology News

Design limitations may have compromised DVT intervention trial

May 14, 2018

Thrombosis

Hematology Times

Rivaroxaban vs dalteparin for VTE in cancer

May 14, 2018

Thrombosis

Hematology Times

How ruxolitinib reduces thrombosis in MPNs

May 8, 2018

Hematology Times

FDA approves antidote for factor Xa inhibitors

May 7, 2018

Hematology News

First reversal agent for apixaban and rivaroxaban gets fast-track approval

May 4, 2018

Thrombosis

Hematology Times

Study shows increased risk of VTE among earthquake evacuees

May 4, 2018

Thrombosis

Hematology Times

Blood type linked to death risk after trauma

May 4, 2018

Hematology News

NHLBI seeks to accelerate hemostasis/thrombosis research

May 3, 2018

Hematology Times

Single injection could treat hemophilia B long-term

May 3, 2018

Hematology News

Does warfarin cause acute kidney injury?

May 2, 2018

Thrombosis

Hematology Times

PI3K inhibitors could treat HHT

May 2, 2018

Hematology Times

Fostamatinib produces responses in ITP

May 1, 2018